Intra Cellular Therapies Probability of Future Stock Price Finishing Over 131.87
| ITCIDelisted Stock | USD 131.87 0.03 0.02% |
Intra |
Intra Cellular Target Price Odds to finish over 131.87
The tendency of Intra Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 131.87 | 90 days | 131.87 | about 27.21 |
Based on a normal probability distribution, the odds of Intra Cellular to move above the current price in 90 days from now is about 27.21 (This Intra Cellular Therapies probability density function shows the probability of Intra Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Intra Cellular Therapies has a beta of -1.07. This usually indicates Additionally Intra Cellular Therapies has an alpha of 0.988, implying that it can generate a 0.99 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Intra Cellular Price Density |
| Price |
Predictive Modules for Intra Cellular
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Intra Cellular Therapies. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Intra Cellular's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intra Cellular Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Intra Cellular is not an exception. The market had few large corrections towards the Intra Cellular's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Intra Cellular Therapies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Intra Cellular within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.99 | |
β | Beta against Dow Jones | -1.07 | |
σ | Overall volatility | 16.77 | |
Ir | Information ratio | 0.11 |
Intra Cellular Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Intra Cellular for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Intra Cellular Therapies can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Intra Cellular is not yet fully synchronised with the market data | |
| Intra Cellular has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 680.85 M. Net Loss for the year was (74.68 M) with profit before overhead, payroll, taxes, and interest of 387.77 M. | |
| Intra Cellular Therapies currently holds about 628.74 M in cash with (73.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.64. | |
| Over 96.0% of the company shares are owned by institutional investors |
Intra Cellular Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Intra Stock often depends not only on the future outlook of the current and potential Intra Cellular's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Intra Cellular's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 103.1 M | |
| Cash And Short Term Investments | 1 B |
Intra Cellular Technical Analysis
Intra Cellular's future price can be derived by breaking down and analyzing its technical indicators over time. Intra Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Intra Cellular Therapies. In general, you should focus on analyzing Intra Stock price patterns and their correlations with different microeconomic environments and drivers.
Intra Cellular Predictive Forecast Models
Intra Cellular's time-series forecasting models is one of many Intra Cellular's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Intra Cellular's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Intra Cellular Therapies
Checking the ongoing alerts about Intra Cellular for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Intra Cellular Therapies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Intra Cellular is not yet fully synchronised with the market data | |
| Intra Cellular has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 680.85 M. Net Loss for the year was (74.68 M) with profit before overhead, payroll, taxes, and interest of 387.77 M. | |
| Intra Cellular Therapies currently holds about 628.74 M in cash with (73.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.64. | |
| Over 96.0% of the company shares are owned by institutional investors |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Intra Stock
If you are still planning to invest in Intra Cellular Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intra Cellular's history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |